/Companies

Ossium Health

San Francisco, US · Founded 2016 · Delaware corporation · 105 employees on LinkedIn · 11 known investors

Find your way into Ossium Health

Sign up to see every warm intro you have to Ossium Health

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ossium Health team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Ossium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms. The company operates as a clinical-stage biotech firm manufacturing and distributing cellular therapeutics for patients with organ and tissue diseases.

Founders & leadership

Ossium Health was founded in 2016 by Kevin Caldwell, Dr. Woods, Sebastian Giwa, and Erik Woods.

KCKevin Caldwell
Kevin CaldwellFounderKevin Caldwell is CEO and co-founder of Ossium Health, a clinical-stage biotech company developing cellular therapies using adult stem cell technologies. He previously worked as an Engagement Manager at McKinsey's San Francisco office focusing on technology clients and as a Senior Investment Associate at Bridgewater Associates conducting quantitative research, and holds degrees from MIT and Harvard Law School.
DW
Dr. WoodsChief Science Officer, Co-Founder, EVP, CLIA Laboratory Director
SGSebastian Giwa
Sebastian GiwaFounder, CEO and Executive Chairman2014–2018Sebastian Giwa holds a PhD in Economics from Stockholm School of Economics and Harvard, and an MBA from Harvard Business School. He has founded multiple biotech companies including Ossium Health, Sylvatica Biotech, Elevian, and Expanse Bio, and previously worked in research and investing at Bridgewater Associates and in consulting at Bain and Goldman Sachs.
EWErik Woods
Erik WoodsCo Founder, Executive Vice President and Chief Science OfficerHe previously co-founded General BioTechnology LLC, which was acquired by COOK Medical, and held an officer role at Medistem, Inc., which was acquired by Intrexon Corp, bringing expertise in biotech operations, regulatory affairs, and quality systems.

Board

WTWilliam Trenchard
William TrenchardBoard directorPartner at First Round Capital
TC
Thomas CycyotaBoard director

Investors · 11

Reported raises · per SEC filings

Form D private placements

$10.4M disclosed across 1 round · 2018

▶$10.4MraisedMay 2018 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William TrenchardDirector
  • Kevin CaldwellExecutive Officer, Director
  • Erik WoodsExecutive Officer, Director
  • Sebastian GiwaDirector
  • Thomas CycyotaDirector
Offering amount
$10.4M
Amount sold
$10.4M
First sale
May 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Ossium Health.

Non-dilutive funding · 9 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2021$248.5K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2021$224.5K
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$300K
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$299.9K
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$225K
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$272.6K
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$239.1K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Ossium Health do?
Ossium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms. The company operates as a clinical-stage biotech firm manufacturing and distributing cellular therapeutics for patients with organ and tissue diseases.
Who founded Ossium Health?
Ossium Health was founded by Kevin Caldwell, Dr. Woods, Sebastian Giwa, Erik Woods in 2016.
Who are Ossium Health's investors?
Ossium Health's investors include Alumni Ventures, FemHealth Ventures, First Round Capital, General Catalyst, Hemisphere Ventures LLC, Manta Ray Ventures, Mount Pleasant Ventures, Vivo Capital and 3 more.
How much funding has Ossium Health raised?
Ossium Health has disclosed $10.4M raised across 1 round.
Where is Ossium Health headquartered?
Ossium Health is headquartered in San Francisco, US.